Version history

{
  "session_id": "hyp-debate-664901bf-c76305721d",
  "round_number": 1,
  "agent_persona": "persona-Theorist",
  "agent_backend": "codex",
  "action": "support",
  "content": "Theorist argument for 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':\nThe hypothesis is mechanistically plausible because it names ubiquitylation-dependent turnover / ubiquitylation-dependent turnover as an upstream, testable driver in neurodegeneration, not merely a downstream correlate. The stated experimental logic is: The gap can be tested by treating ubiquitylation-dependent turnover as an upstream driver rather than a passive correlate. If true, perturbing E3 ligase mapping should shift UBQLN2 puncta lifetime before downstream neurodegeneration markers change.\n\nSupporting evidence read before debate:\n- four_round_gap_debate [four_round_gap_debate]\n- TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]\n- Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]\n- Neurotrophins and neurodegeneration. [12787319]\n\nThe strongest version of the claim is falsifiable: an intervention or stratification that shifts the ubiquitylation-dependent turnover readout should precede measurable changes in downstream neurodegeneration markers. The hypothesis also has practical value because it identifies a biomarker or perturbation axis that can be measured longitudinally rather than relying on cross-sectional association alone.",
  "hypotheses_referenced": "h-gap-92152803-m1",
  "evidence_cited": "[\"four_round_gap_debate [four_round_gap_debate]\", \"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]\", \"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]\", \"Neurotrophins and neurodegeneration. [12787319]\"]",
  "confidence": 0.743,
  "argument": "Theorist argument for 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':\nThe hypothesis is mechanistically plausible because it names ubiquitylation-dependent turnover / ubiquitylation-dependent turnover as an upstream, testable driver in neurodegeneration, not merely a downstream correlate. The stated experimental logic is: The gap can be tested by treating ubiquitylation-dependent turnover as an upstream driver rather than a passive correlate. If true, perturbing E3 ligase mapping should shift UBQLN2 puncta lifetime before downstream neurodegeneration markers change.\n\nSupporting evidence read before debate:\n- four_round_gap_debate [four_round_gap_debate]\n- TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]\n- Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]\n- Neurotrophins and neurodegeneration. [12787319]\n\nThe strongest version of the claim is falsifiable: an intervention or stratification that shifts the ubiquitylation-dependent turnover readout should precede measurable changes in downstream neurodegeneration markers. The hypothesis also has practical value because it identifies a biomarker or perturbation axis that can be measured longitudinally rather than relying on cross-sectional association alone.",
  "evidence": "[\"four_round_gap_debate [four_round_gap_debate]\", \"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]\", \"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]\", \"Neurotrophins and neurodegeneration. [12787319]\"]"
}